BG103648A - Paroxetin-containing compositions - Google Patents

Paroxetin-containing compositions

Info

Publication number
BG103648A
BG103648A BG103648A BG10364899A BG103648A BG 103648 A BG103648 A BG 103648A BG 103648 A BG103648 A BG 103648A BG 10364899 A BG10364899 A BG 10364899A BG 103648 A BG103648 A BG 103648A
Authority
BG
Bulgaria
Prior art keywords
paroxetin
containing compositions
solutions
anhydrate
atomization
Prior art date
Application number
BG103648A
Other languages
Bulgarian (bg)
English (en)
Inventor
Victor JACEWICZ
Neal Ward
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700692.8A external-priority patent/GB9700692D0/en
Priority claimed from GBGB9714873.8A external-priority patent/GB9714873D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103648A publication Critical patent/BG103648A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG103648A 1997-01-15 1999-08-10 Paroxetin-containing compositions BG103648A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9700692.8A GB9700692D0 (en) 1997-01-15 1997-01-15 Novel process and compound
GBGB9714873.8A GB9714873D0 (en) 1997-07-15 1997-07-15 Novel process and compound
PCT/GB1998/000081 WO1998031365A1 (en) 1997-01-15 1998-01-12 Paroxetine compositions

Publications (1)

Publication Number Publication Date
BG103648A true BG103648A (en) 2000-04-28

Family

ID=26310796

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103648A BG103648A (en) 1997-01-15 1999-08-10 Paroxetin-containing compositions

Country Status (21)

Country Link
US (1) US20010049442A1 (id)
EP (1) EP0952831A1 (id)
JP (1) JP2001508460A (id)
KR (1) KR20000070151A (id)
CN (1) CN1249686A (id)
AP (1) AP9901604A0 (id)
AU (1) AU730532B2 (id)
BG (1) BG103648A (id)
BR (1) BR9806754A (id)
CA (1) CA2277480A1 (id)
EA (1) EA002034B1 (id)
HU (1) HUP0000960A3 (id)
ID (1) ID23250A (id)
IL (1) IL130856A (id)
NO (1) NO993460L (id)
NZ (1) NZ336587A (id)
OA (1) OA11077A (id)
PL (1) PL334568A1 (id)
SK (1) SK95099A3 (id)
TR (1) TR199901622T2 (id)
WO (1) WO1998031365A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
PT1100796E (pt) * 1998-08-07 2003-09-30 Smithkline Beecham Plc Processo para a preparacao de um cloridrato de paroxetina na forma anidra nao cristalina
GB9824298D0 (en) * 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
ATE311883T1 (de) 1999-03-12 2005-12-15 Aesica Pharmaceuticals Ltd Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
ES2162560B1 (es) * 1999-06-25 2002-07-16 Rodriguez Concepcion Pena Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.
US6984632B1 (en) 1999-07-01 2006-01-10 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
GB9919052D0 (en) * 1999-08-12 1999-10-13 Smithkline Beecham Plc Novel compound composition and process
GB9923439D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
SK95099A3 (en) 2000-01-18
WO1998031365A1 (en) 1998-07-23
AU730532B2 (en) 2001-03-08
NO993460L (no) 1999-09-14
CN1249686A (zh) 2000-04-05
JP2001508460A (ja) 2001-06-26
EA002034B1 (ru) 2001-12-24
US20010049442A1 (en) 2001-12-06
IL130856A (en) 2001-09-13
HUP0000960A2 (hu) 2001-02-28
AU5567398A (en) 1998-08-07
CA2277480A1 (en) 1998-07-23
AP9901604A0 (en) 1999-09-30
NO993460D0 (no) 1999-07-14
HUP0000960A3 (en) 2001-04-28
ID23250A (id) 2000-03-30
OA11077A (en) 2003-03-13
EA199900655A1 (ru) 2000-02-28
PL334568A1 (en) 2000-03-13
EP0952831A1 (en) 1999-11-03
BR9806754A (pt) 2000-03-14
TR199901622T2 (xx) 1999-09-21
KR20000070151A (ko) 2000-11-25
NZ336587A (en) 2001-01-26
IL130856A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
NZ236581A (en) 3-amino piperidine derivatives, analogues and pharmaceutical compositions
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
EP0992501A3 (en) Pyridonecarboxylic acid derivatives as antibacterial agents
CA2334730A1 (en) Novel cyclosporins
HUP0204034A3 (en) Stable salts of novel derivatives of 3,3-diphenylpropylamines
CA2414018A1 (en) 2-aminocarbonyl-9h-purine derivatives
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
PL325312A1 (en) Methaguanidine, urea, thiourea or azacyclic derivatives of aminobenzoic acid as antagonists of integrin
CA2206233A1 (en) Combination dosage form comprising cetirizine and pseudoephedrine
WO2000039083A3 (en) Pyrazole compounds and uses thereof
EP2308496A3 (en) Formulation containing phosphate derivatives of electron transfer agents
BG103863A (en) Indazolamide compounds as serotoninergic forms
IE801152L (en) Enkephalin derivatives
ATE214698T1 (de) Neue carbamazepin hapten analoge
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
MY123083A (en) Acyclic nucleoside derivatives
MX9500363A (es) Monohiddrato de (e)-2'-desoxi-2'- (fluorometilen) citidina.
AP9901604A0 (en) Paroxetine compositions.
CA2383351A1 (en) Xanthine derivatives as selective antagonists of a2b adenosine receptors
MX9801967A (es) Tetrahidroquinolinas como antagonistas de los aminoacidos excitadores (nmda).
WO2002032901A3 (en) Bridged piperazine derivatives
GR3003738T3 (id)
WO1999005103A3 (en) 2o(s)-7-ethyl-9-(n-methyl-n-phenyl)amidino-camptothecin, its preparation and its use as antitumor agent